Megestrol Acetate Oral Suspension — Class II drug recall D-1172-2018
Terminated recall by Mckesson Corporation, reported 2018-09-12, distributed nationwide. Supterpotent Drug
| Recall number | D-1172-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Corporation, Memphis, TN, United States |
| Recall initiated | 2018-08-14 |
| Classified | 2018-09-05 |
| Reported by FDA | 2018-09-12 |
| Terminated | 2020-11-25 |
| Distributed | Nationwide (US) |
| Quantity | 1,531 cartons |
| NDC | 63739-0549-51 |
| Lot numbers | 0113901, 0113902, 0113903, 0116158 |
| Expiration dates | 2018-08-31, 2019-04-30 |
Product
Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes of 20 cups), Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977 Dist. By: McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63739-549-51
Reason for recall
Supterpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1172-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.